These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30114477)

  • 41. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms.
    Ross D; Kepa JK; Winski SL; Beall HD; Anwar A; Siegel D
    Chem Biol Interact; 2000 Dec; 129(1-2):77-97. PubMed ID: 11154736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic silencing of NAD(P)H:quinone oxidoreductase 1 by hepatitis B virus X protein increases mitochondrial injury and cellular susceptibility to oxidative stress in hepatoma cells.
    Wu YL; Wang D; Peng XE; Chen YL; Zheng DL; Chen WN; Lin X
    Free Radic Biol Med; 2013 Dec; 65():632-644. PubMed ID: 23920313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NQO1 regulates cell cycle progression at the G2/M phase.
    Oh ET; Kim HG; Kim CH; Lee J; Kim C; Lee JS; Cho Y; Park HJ
    Theranostics; 2023; 13(3):873-895. PubMed ID: 36793872
    [No Abstract]   [Full Text] [Related]  

  • 44. Arsenite and cadmium, but not chromium, induce NAD(P)H:quinone oxidoreductase 1 through transcriptional mechanisms, in spite of post-transcriptional modifications.
    Elbekai RH; El-Kadi AO
    Toxicol In Vitro; 2008 Aug; 22(5):1184-90. PubMed ID: 18474416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells.
    Reigan P; Colucci MA; Siegel D; Chilloux A; Moody CJ; Ross D
    Biochemistry; 2007 May; 46(20):5941-50. PubMed ID: 17455910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway.
    Piracha ZZ; Kwon H; Saeed U; Kim J; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.
    Damodaran S; Damaschke N; Gawdzik J; Yang B; Shi C; Allen GO; Huang W; Denu J; Jarrard D
    BMC Cancer; 2017 Dec; 17(1):874. PubMed ID: 29262808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.
    Basu S; Brown JE; Flannigan GM; Gill JH; Loadman PM; Martin SW; Naylor B; Puri R; Scally AJ; Seargent JM; Shah T; Phillips RM
    Int J Oncol; 2004 Oct; 25(4):921-7. PubMed ID: 15375541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA.
    Zhang H; Head PE; Daddacha W; Park SH; Li X; Pan Y; Madden MZ; Duong DM; Xie M; Yu B; Warren MD; Liu EA; Dhere VR; Li C; Pradilla I; Torres MA; Wang Y; Dynan WS; Doetsch PW; Deng X; Seyfried NT; Gius D; Yu DS
    Cell Rep; 2016 Feb; 14(6):1435-1447. PubMed ID: 26854234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Down-regulation of the detoxifying enzyme NAD(P)H:quinone oxidoreductase 1 by vanadium in Hepa 1c1c7 cells.
    Anwar-Mohamed A; El-Kadi AO
    Toxicol Appl Pharmacol; 2009 May; 236(3):261-9. PubMed ID: 19367690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
    Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
    Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger.
    Zhu H; Jia Z; Mahaney JE; Ross D; Misra HP; Trush MA; Li Y
    Cardiovasc Toxicol; 2007; 7(3):202-11. PubMed ID: 17901563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional regulation of the human NAD(P)H:quinone oxidoreductase (NQO1) gene by monofunctional inducers.
    Wang B; Williamson G
    Biochim Biophys Acta; 1996 Jun; 1307(1):104-10. PubMed ID: 8652659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acupuncture may exert its therapeutic effect through microRNA-339/Sirt2/NFκB/FOXO1 axis.
    Wang JY; Li H; Ma CM; Wang JL; Lai XS; Zhou SF
    Biomed Res Int; 2015; 2015():249013. PubMed ID: 25695055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6.
    Skoge RH; Ziegler M
    J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
    Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D
    Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NQO1 Deficiency Leads Enhanced Autophagy in Cisplatin-Induced Acute Kidney Injury Through the AMPK/TSC2/mTOR Signaling Pathway.
    Kim TW; Kim YJ; Kim HT; Park SR; Lee MY; Park YD; Lee CH; Jung JY
    Antioxid Redox Signal; 2016 May; 24(15):867-83. PubMed ID: 26935540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis.
    Wondrak GT
    Free Radic Biol Med; 2007 Jul; 43(2):178-90. PubMed ID: 17603928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CHM-1, a novel microtubule-destabilizing agent exhibits antitumor activity via inducing the expression of SIRT2 in human breast cancer cells.
    Liu CW; Lin YC; Hung CM; Liu BL; Kuo SC; Ho CT; Way TD; Hung CH
    Chem Biol Interact; 2018 Jun; 289():98-108. PubMed ID: 29679549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
    Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
    PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.